TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/NASDAQ/KURA

Kura Oncology Inc (KURA : NASDAQ)

Common Stock

$11.20

USD

+0.00 (%)

Last updated: 2026-09-17

Get KURA alerts:

KURA

Kura Oncology Inc

Source:WealthAwesomeWealthAwesome
$2.44 (26.29%)
30 day period
$9.28$11.43$13.59Aug 6Aug 27Sep 17

Performance

1 Day

-0.88%

1 Week

-7.36%

1 Month

-0.71%

YTD

+17.03%

Key Statistics

Market Cap

$996.36M

52W High

$13.90

52W Low

$7.36

P/E Ratio

-

50 Day MA

$11.18

200 Day MA

$9.82

Beta

0.43

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/17/2026$11.39$12.20$11.35$11.72$11.721,852,046
9/16/2026$11.31$11.52$11.14$11.20$11.201,793,131
9/15/2026$11.48$11.48$11.03$11.30$11.301,827,385
9/14/2026$11.37$11.68$11.25$11.56$11.561,457,824
9/11/2026$11.58$11.75$11.34$11.39$11.392,117,528
9/10/2026$12.00$12.00$11.44$11.57$11.571,814,433
9/9/2026$12.50$12.61$11.99$12.09$12.092,213,106
9/8/2026$12.93$12.93$12.50$12.52$12.521,511,765
9/4/2026$12.94$13.27$12.89$13.25$13.251,313,519
9/3/2026$13.25$13.29$12.85$13.15$13.151,477,983

Analyst Price Targets

Based on 15 analysts covering KURA · as of Sep 17, 2026

📈

Wall Street analysts forecast KURA stock price to rise 185.7% over the next 12 months.

Consensus

Strong Buy

4.53 / 5.00

Avg. Target

US$32.00

+185.7% Upside

Current Price

US$11.20

Last close

Analyst Breakdown (15 analysts)

Strong Buy 10
Buy 3
Hold 2
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on KURA's historical volatility

HistoricalForecast68%95%
US$6.51US$11.23US$15.96US$20.69US$25.41US$30.14TodayJun 17Aug 4Sep 17Oct 30Dec 13Jan 25

30-Day Vol

61.6%

Annualized

90-Day Vol

58.5%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

US$14.01

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$12.44US$10.06US$15.38
60 trading daysUS$13.20US$9.77US$17.83
90 trading daysUS$14.01US$9.70US$20.25

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Kura Oncology Inc

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.

Financials

Revenue (TTM)
$77.22M
EBITDA
$-316.80M
Profit Margin
0.00%
ROE (TTM)
-167.71%
EPS (Diluted)
-3.37
Book Value
0.54

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About KURA.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
DLXYDelixy Holdings Limited Ordinary Shares$2.29+451.81%
MEDSDataMEDS AI, Inc.$6.07+274.69%
SNYRSynergy CHC Corp. Common Stock$0.27+234.15%
QCLSQ/C Technologies, Inc.$0.96+118.45%
AEHLAntelope Enterprise Holdings Ltd$9.22+78.68%
ZTGZenta Group Company Limited$1.18+75.33%
PDSBPDS Biotechnology Corp$0.99+69.25%
TPSTTempest Therapeutics Inc$1.21+60.18%

Advertisement